| Profile | GDS4177 / 210101_x_at |
| Title | Imatinib treatment of chronic myeloid leukemia cell lines: KU-812, KCL-22 and JURL-MK1 |
| Organism | Homo sapiens |
| Sample | Title | Value | Rank |
|---|---|---|---|
| GSM603100 | KU-812 Imatinib-treated | 1744.68 | 97 |
| GSM603099 | KU-812 non-treated | 1174.76 | 96 |
| GSM603098 | KCL-22 Imatinib-treated | 1154.61 | 96 |
| GSM603097 | KCL-22 non-treated | 935.79 | 94 |
| GSM603102 | JURL-MK1 Imatinib-treated | 943.39 | 95 |
| GSM603101 | JURL-MK1 non-treated | 719.87 | 93 |